Market positioning EndyMed Medical operates in the medical aesthetics space with FDA-cleared 3DEEP RF technology, serving both professional and consumer segments. This dual-market approach presents opportunities to upsell professional platforms to clinics and to expand consumer adoption through at-home systems like NEWA.

Product breadth Two professional platforms (PRO and PURE+) with multiple handpieces plus a consumer line (NEWA) and accompanying gels/creams create cross-sell and bundled upsell opportunities across clinical settings and at-home treatment adoption.

Growth signals Recent leadership additions in the US subsidiary and technology advisory roles indicate ongoing strategic expansion and validation efforts, suggesting readiness for targeted sales outreach to US clinics, medspas, and dermatology practices.

Financial runway With a revenue range of $25M-$50M and a relatively lean team, EndyMed presents an attractive opportunity for partnerships and capex deals, highlighting potential for higher-margin equipment sales, service contracts, and training programs.

Competitive edge 3DEEP’s multi-depth RF delivery and skin penetration independent of skin color position EndyMed as a differentiator in non-ablative wrinkle reduction and skin tightening, enabling targeted campaigns to clinics serving diverse patient populations.